15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering ArcBest Corp, 7 rate it Buy or better, 5 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $84.00 to $180.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $152.92 sits 2% above the current $149.36. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 6 to 7 over recent months. On the fundamentals, the Street sees revenue growth near 9% this year and 6% next, consensus EPS building from about $2.28 next quarter toward $9.33 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Moderate Buy
Strong Buy00%
Buy758%
Hold542%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to ArcBest Corp.
As of Jul, 7 of 12 firms rate ARCB a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ARCB EPS & revenue forecast
EPS · NEXT QUARTER
$2.28
Range $1.75 – $2.75 · 13 analysts · +56% YoY
Next period, 13 analysts expect ArcBest Corp to earn $2.28 a share (range $1.75 – $2.75), versus $1.46 a year earlier. Full-year consensus is $6.55, growing to $9.33 the year after.
REVENUE · NEXT QUARTER
$1.2B
Range $1.1B – $1.2B · 13 analysts · +9% YoY
Revenue is expected to reach $1.2B (range $1.1B – $1.2B), +9.0% year-over-year. Full-year consensus is $4.5B, rising to $4.8B next year.
Top analysts covering ArcBest Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ARCB.
#1
Ken Hoexter
B of A Securities · Rank #199
Hold
$160.00+7.1% to target
Overall win rate
44%
+ Follow
#2
Ariel Rosa
Citigroup
Buy
$178.00+19.2% to target
Coverage
—
+ Follow
#3
JB
J. Bruce Chan
Stifel
Buy
$176.00+17.8% to target
Coverage
—
+ Follow
#4
Thomas Wadewitz
UBS
Hold
$145.00-2.9% to target
Coverage
—
+ Follow
#5
Brian Ossenbeck
JP Morgan
Hold
$147.00-1.6% to target
Coverage
—
+ Follow
ARCB stock forecast FAQ
What is ARCB's average 12-month price target?+
The 12 analysts with a live target average $152.92 for ArcBest Corp over the next 12 months, ranging from a $180.00 high to a $84.00 low.
Is ARCB stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 12 analyst ratings, 7 are Buy or Strong Buy, 5 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ARCB?+
The Street-high target is $180.00 (Citizens), and the Street-low is $84.00 (B of A Securities). The average of all 12 active targets is $152.92.
How many Wall Street analysts cover ARCB?+
12 analysts have an active rating on ArcBest Corp, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering ARCB?+
Among analysts who currently cover ARCB, Ken Hoexter of B of A Securities has the strongest overall Quantellect track record (Rank #199). Their current call is Hold with a $160.00 target.
What is ArcBest Corp's projected EPS for next quarter?+
The consensus estimate is $2.28 per share (range $1.75 – $2.75) across 13 analysts. Full-year EPS is projected at $6.55, rising to $9.33 the following year.
How much revenue is ArcBest Corp expected to report next quarter?+
Consensus revenue is $1.2B (range $1.1B – $1.2B). Full-year revenue is projected at $4.5B, growing to $4.8B next year.
Have analysts been upgrading or downgrading ARCB lately?+
As of Jul, 7 of 12 firms rate ARCB a Buy (5 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ARCB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Citizens
